Brief: Lyell Posts Quarterly Revenue $2.8 Million
12/11/2021 14:38
Nov 12 (Reuters) - Lyell Immunopharma Inc LYEL.O :
* LYELL IMMUNOPHARMA REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND BUSINESS HIGHLIGHTS
* LYELL IMMUNOPHARMA INC - QTRLY REVENUE $2.8 MILLION VERSUS
$1.1
MILLION
* LYELL IMMUNOPHARMA INC - QTRLY NET LOSS $48.9 MILLION
VERSUS
$35.7 MILLION
Source text for Eikon: ID:nGNX9Xm7xl
Further company coverage: LYEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma